Can B Corp (CANB)

[sleekscape]

CANB is a CBD Oil company that has 3 revenue generating divisions — Medical CBD, Retail CBD and Medical Device CBD

Canbiola — Medical CBD

Pure Leaf — Retail CBD

Duramed — Medical Device CBD (SAM)


My DD on the company is posted here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148790697

This is the most recent CANB interview and it is a must-listen:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148357871


The revenue growth CANB achieved during the last quarter, as well as for the full year 2018, was extremely impressive

Here are the 2018 quarterly revenues, which consisted almost entirely of Canbiola Medical CBD product sales:

Q1 — $69,000

Q2 — $154,000

Q3 — $163,000

Q4 — $281,000


The annual revenue growth was outstanding:

2017 Annual Revenue — $122,000

2018 Annual Revenue — $668,000


I am very much looking forward to reading the Q1 10-Q

I’m excited to see what the revenues will look like, as we are getting our first taste of CBD Medical Device revenue from SAM, which launched in February

The market’s reaction to the fantastic revenue growth in Q4 was very strong — CANB doubled from .03 to .06 — so it will be interesting to see the market’s reaction to the Q1 report

The escalating quarterly revenue growth moving forward in 2019 is the crux of the fundamental argument for investing in CANB this year


Sleek